EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples

Sarah Mafi iD, Flavie Theuillon, Sylvain Meyer iD, Jean-Baptiste Woillard, Marine Dupont iD, Sylvie Rogez, Sophie Alain, Sébastien Hantz

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0320978 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Sarah Mafi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Virology and Hygiene, CHU Limoges, Limoges, France. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomaviridae, Cervix Uteri. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seegene.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Human papillomavirus (HPV) genotyping is essential for cervical cancer screening and prevention. The Allplex TM HPV28 real-time PCR kit, using different chemistry and results analysis compared with its predecessor, the Anyplex TM II HPV28 kit, has recently been launched. This study aims to compare the Allplex TM HPV28 and Anyplex TM II HPV28 assays in detecting and genotyping the 13 high-risk (HR)-HPV types. Study design Between 2022 and 2023, 459 cervical samples from women undergoing cervical cancer screening were selected. These samples were analysed by liquid-based cytology and tested by both kits concurrently.

Results

Allplex TM HPV28 Ct values correlated well with Anyplex TM II HPV28 signal intensity scores. No significant differences between assays were observed in overall and genotype-specific HR-HPV prevalence determined in all samples and according to cytological results. In addition, no significant differences were identified between assays in the detection of single and multiple HR-HPV infections. Most of the discordant results corresponded to samples showing weak HR-HPV signals and multiple HR-HPV types.

Conclusions

Our results demonstrate that the Allplex TM HPV28 kit can be used for HPV genotyping, with results overall similar to those obtained with the Anyplex TM II HPV28 kit and the addition of Ct values for patient follow-up. The clinical implications of the potentially reduced sensitivity of the Allplex TM HPV28 kit in detecting HPV31 ( p = 0.07) and HPV39 ( p = 0.08) warrant further investigation in subsequent studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsPapillomaviridaeCervix UteriGenotyping TechniquesHumansFemaleGenotypeAdultMiddle AgedEarly Detection of CancerReagent Kits, DiagnosticDNA, ViralReal-Time Polymerase Chain ReactionAlphapapillomavirus

Substanzen

Reagent Kits, DiagnosticDNA, Viral

Autor:innen und Institutionen

  • Department of Bacteriology, Virology and Hygiene, CHU Limoges, Limoges, France.
  • University of Limoges, INSERM, RESINFIT, U1092, Limoges, France.
  • Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France.

ORCID-Profile: Sarah Mafi, Sylvain Meyer, Marine Dupont

Förderung

  • Seegene

Zitieren

APA

Mafi, S., Theuillon, F., Meyer, S., Woillard, J. B., Dupont, M., Rogez, S., Alain, S., & Hantz, S. (2025). Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples. PLOS ONE. https://doi.org/10.1371/journal.pone.0320978

Vancouver

Mafi S, Theuillon F, Meyer S, Woillard JB, Dupont M, Rogez S, et al. Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples. PLOS ONE. 2025. doi:10.1371/journal.pone.0320978

BibTeX
@article{Mafi2025,
  author = {Mafi, Sarah and Theuillon, Flavie and Meyer, Sylvain and Woillard, Jean-Baptiste and Dupont, Marine and Rogez, Sylvie and Alain, Sophie and Hantz, Sébastien},
  title = {Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0320978}
}
Kostenlos starten →